SEARCH

SEARCH BY CITATION

References

  • Bennicelli, J.L., and Guerry, D.T. (1993). Production of multiple cytokines by cultured human melanomas. Exp. Dermatol. 2, 186190.
  • Bernengo, M.G., Quaglino, P., Cappello, N., Lisa, F., Osella-Abate, S., and Fierro, M.T. (2000). Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients. Melanoma Res. 10, 5565.
  • Biswas, S.K., and Mantovani, A. (2010). Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11, 889896.
  • Biswas, S.K., Sica, A., and Lewis, C.E. (2008). Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J. Immunol. 180, 20112017.
  • Brocker, E.B., Zwadlo, G., Suter, L., Brune, M., and Sorg, C. (1987). Infiltration of primary and metastatic melanomas with macrophages of the 25F9-positive phenotype. Cancer Immunol. Immunother. 25, 8186.
  • Brocker, E.B., Zwadlo, G., Holzmann, B., Macher, E., and Sorg, C. (1988). Inflammatory cell infiltrates in human melanoma at different stages of tumor progression. Int. J. Cancer 41, 562567.
  • Dean, R.A., Cox, J.H., Bellac, C.L., Doucet, A., Starr, A.E., and Overall, C.M. (2008). Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx. Blood 112, 34553464.
  • Duluc, D., Delneste, Y., Tan, F. et al. (2007). Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood 110, 43194330.
  • Facchetti, F., Bertalot, G., and Grigolato, P.G. (1991). KP1 (CD 68) staining of malignant melanomas. Histopathology 19, 141145.
  • Gazzaniga, S., Bravo, A.I., Guglielmotti, A., Van Rooijen, N., Maschi, F., Vecchi, A., Mantovani, A., Mordoh, J., and Wainstok, R. (2007). Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft. J. Invest. Dermatol. 127, 20312041.
  • Ilkovitch, D., and Lopez, D.M. (2008). Immune modulation by melanoma-derived factors. Exp. Dermatol. 17, 977985.
  • Jensen, T.O., Schmidt, H., Moller, H.J., Hoyer, M., Maniecki, M.B., Sjoegren, P., Christensen, I.J., and Steiniche, T. (2009). Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma. J. Clin. Oncol. 27, 33303337.
  • Kessenbrock, K., Plaks, V., and Werb, Z. (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 5267.
  • Kono, K., Salazar-Onfray, F., Petersson, M., Hansson, J., Masucci, G., Wasserman, K., Nakazawa, T., Anderson, P., and Kiessling, R. (1996). Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity. Eur. J. Immunol. 26, 13081313.
  • Kuan, C.T., Wakiya, K., Keir, S.T., Li, J., Herndon II, J.E., Pastan, I., and Bigner, D.D. (2011). Affinity-matured anti-glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomas. Int. J. Cancer 129, 111121.
  • Lazar-Molnar, E., Hegyesi, H., Toth, S., and Falus, A. (2000). Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 12, 547554.
  • Makitie, T., Summanen, P., Tarkkanen, A., and Kivela, T. (2001). Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma. Invest. Ophthalmol. Vis. Sci. 42, 14141421.
  • Mantovani, A., and Sica, A. (2010). Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr. Opin. Immunol. 22, 231237.
  • Marconi, C., Bianchini, F., Mannini, A., Mugnai, G., Ruggieri, S., and Calorini, L. (2008). Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells. Clin. Exp. Metastasis 25, 225231.
  • Metz, R.L., Patel, P.S., Hameed, M., Bryan, M., and Rameshwar, P. (2007). Role of human HGFIN/nmb in breast cancer. Breast Cancer Res. 9, R58.
  • Monti, P., Leone, B.E., Marchesi, F. et al. (2003). The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity. Cancer Res. 63, 74517461.
  • Mosser, D.M., and Edwards, J.P. (2008). Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958969.
  • Munn, D.H., Shafizadeh, E., Attwood, J.T., Bondarev, I., Pashine, A., and Mellor, A.L. (1999). Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189, 13631372.
  • Ogawa, T., Nikawa, T., Furochi, H. et al. (2005). Osteoactivin upregulates expression of MMP-3 and MMP-9 in fibroblasts infiltrated into denervated skeletal muscle in mice. Am. J. Physiol. Cell Physiol. 289, C697C707.
  • Onaga, M., Ido, A., Hasuike, S., Uto, H., Moriuchi, A., Nagata, K., Hori, T., Hayash, K., and Tsubouchi, H. (2003). Osteoactivin expressed during cirrhosis development in rats fed a choline-deficient, L-amino acid-defined diet, accelerates motility of hepatoma cells. J. Hepatol. 39, 779785.
  • Paglia, D., Oran, A., Lu, C., Kerbel, R.S., Sauder, D.N., and Mckenzie, R.C. (1995). Expression of leukemia inhibitory factor and interleukin-11 by human melanoma cell lines: LIF, IL-6, and IL-11 are not coregulated. J. Interferon Cytokine Res. 15, 455460.
  • Payne, A.S., and Cornelius, L.A. (2002). The role of chemokines in melanoma tumor growth and metastasis. J. Invest. Dermatol. 118, 915922.
  • Porta, C., Subhra Kumar, B., Larghi, P., Rubino, L., Mancino, A., and Sica, A. (2007). Tumor promotion by tumor-associated macrophages. Adv. Exp. Med. Biol. 604, 6786.
  • Qian, B.Z., and Pollard, J.W. (2010). Macrophage diversity enhances tumor progression and metastasis. Cell 141, 3951.
  • Rich, J.N., Shi, Q., Hjelmeland, M., Cummings, T.J., Kuan, C.T., Bigner, D.D., Counter, C.M., and Wang, X.F. (2003). Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model. J. Biol. Chem. 278, 1595115957.
  • Richmond, A., Yang, J., and Su, Y. (2009). The good and the bad of chemokines/chemokine receptors in melanoma. Pigment Cell Melanoma Res. 22, 175186.
  • Ripoll, V.M., Irvine, K.M., Ravasi, T., Sweet, M.J., and Hume, D.A. (2007). GPMNB is induced in macrophages by IFN-gamma and lipopolysaccharide and acts as a feedback regulator of proinflammatory responses. J. Immunol. 178, 65576566.
  • Robinson, S.C., Scott, K.A., and Balkwill, F.R. (2002). Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha. Eur. J. Immunol. 32, 404412.
  • Rose, A.A., and Siegel, P.M. (2010). Emerging therapeutic targets in breast cancer bone metastasis. Future Oncol. 6, 5574.
  • Rose, A.A., Grosset, A.A., Dong, Z. et al. (2010). Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer. Clin. Cancer Res. 16, 21472156.
  • Selim, A.A., Abdelmagid, S.M., Kanaan, R.A., Smock, S.L., Owen, T.A., Popoff, S.N., and Safadi, F.F. (2003). Anti-osteoactivin antibody inhibits osteoblast differentiation and function in vitro. Crit. Rev. Eukaryot. Gene Expr. 13, 265275.
  • Sheng, M.H., Wergedal, J.E., Mohan, S., and Lau, K.H. (2008). Osteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activity. FEBS Lett. 582, 14511458.
  • Sierra-Filardi, E., Puig-Kroger, A., Blanco, F.J., Nieto, C., Bragado, R., Palomero, M.I., Bernabeu, C., Vega, M.A., and Corbi, A.L. (2011). Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers. Blood 117, 50925101.
  • Solinas, G., Germano, G., Mantovani, A., and Allavena, P. (2009). Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J. Leukoc. Biol. 86, 10651073.
  • Solinas, G., Schiarea, S., Liguori, M. et al. (2010). Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility. J. Immunol. 185, 642652.
  • Somasundaram, R., Jacob, L., Swoboda, R. et al. (2002). Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta. Cancer Res. 62, 52675272.
  • Svensson, J., Jenmalm, M.C., Matussek, A., Geffers, R., Berg, G., and Ernerudh, J. (2011). Macrophages at the fetal-maternal interface express markers of alternative activation and are induced by M-CSF and IL-10. J. Immunol. 187, 36713682.
  • Tomihari, M., Chung, J.S., Akiyoshi, H., Cruz, P.D. Jr, and Ariizumi, K. (2010). DC-HIL/glycoprotein Nmb promotes growth of melanoma in mice by inhibiting the activation of tumor-reactive T cells. Cancer Res. 70, 57785787.
  • Torisu, H., Ono, M., Kiryu, H., Furue, M., Ohmoto, Y., Nakayama, J., Nishioka, Y., Sone, S., and Kuwano, M. (2000). Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. Int. J. Cancer 85, 182188.
  • Tse, K.F., Jeffers, M., Pollack, V.A. et al. (2006). CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma. Clin. Cancer Res. 12, 13731382.
  • Tsunawaki, S., Nathan, C.F. (1986). Macrophage deactivation. Altered kinetic properties of superoxide-producing enzyme after exposure to tumor cell-conditioned medium. J. Exp. Med. 164, 13191331.
  • Umemura, N., Saio, M., Suwa, T. et al. (2008). Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics. J. Leukoc. Biol. 83, 11361144.
  • Varney, M.L., Johansson, S.L., and Singh, R.K. (2005). Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: role of monocyte chemotactic protein-1 and vascular endothelial growth factor-A. Melanoma Res. 15, 417425.
  • Waldo, S.W., Li, Y., Buono, C., Zhao, B., Billings, E.M., Chang, J., and Kruth, H.S. (2008). Heterogeneity of human macrophages in culture and in atherosclerotic plaques. Am. J. Pathol. 172, 11121126.
  • Weterman, M.A., Ajubi, N., Van Dinter, I.M., Degen, W.G., Van Muijen, G.N., Ruitter, D.J., and Bloemers, H.P. (1995). nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts. Int. J. Cancer 60, 7381.
  • Williams, M.D., Esmaeli, B., Soheili, A., Simantov, R., Gombos, D.S., Bedikian, A.Y., and Hwu, P. (2010). GPMNB expression in uveal melanoma: a potential for targeted therapy. Melanoma Res. 20, 184190.
  • Zaidi, M.R., Davis, S., Noonan, F.P. et al. (2011). Interferon-gamma links ultraviolet radiation to melanomagenesis in mice. Nature 469, 548553.